CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week The Utility of Rapid Atrial Pacing Immediately Post-TAVR to Predict the Need for Pacemaker Implantation Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study Risk Stratification in PAH Transcatheter Aortic Valve Replacement During Pregnancy Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling

JOURNAL:CBS2017 Article Link

CBS exhibits at EuroPCR 2017 in Paris

CBS2017

Paris, France - Starting from May 16, Left Main & Coronary Bifurcation Summit (CBS) will present the next congress plan at EuroPCR 2017 in Paris. An on-site platform for treatment against left main and coronary bifurcation lesions will be located on the third floor of the Palais des Congrès. All participants and cardiovascular experts are welcomed to CBS booth stand H9 during this 4-day meeting.

On the 10th Summit in this winter, CBS will continue the concept of patient-centric care. Discussion on the objectives like applying big data with well designed RCT to obtain more clinical evidence, incorporation of new interventional technologies and treatment options, integration of hemodynamic evaluation and mechanisms into the treatment, analysis and comparison of treatment options will be put on extra weight. CBS2017 will be helpful to make a comprehensive and in-depth academic exploration on the issue of left main and coronary bifurcation disease.